Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6

Bioscience Reports

Volumn 35, Issue 4, 2015, Pages

  Volz, Yvonne ^a   Koschut, David ^a   Matzke Ogi, Alexandra ^a,f   Dietz, Marina S ^b   Karathanasis, Christos ^b   Richert, Ludovic ^c   Wagner, Moritz G ^d   Mély, Yves ^c   Heilemann, Mike ^b   Niemann, Hartmut H ^e   Orian Rousseau, Véronique ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c Faculté de Pharmacie   (France)

^d AGILENT TECHNOLOGIES   (Germany)

^e BIELEFELD UNIVERSITY   (Germany)

^f AMCURE GMBH   (Germany)

Author keywords

Binding affinity; CD44s; CD44v6; HGF; Met; VEGF

Indexed keywords

CD44V6 ANTIGEN; HEPARAN SULFATE; SCATTER FACTOR; VASCULOTROPIN; HERMES ANTIGEN; HGF PROTEIN, HUMAN; KDR PROTEIN, HUMAN; MET PROTEIN, HUMAN; PROTEIN BINDING; SCATTER FACTOR RECEPTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VEGFA PROTEIN, HUMAN;

ANALYTIC METHOD; ANTIGEN PURIFICATION; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE ANISOTROPY; FLUORESCENCE CORRELATION SPECTROSCOPY; HUMAN; HUMAN CELL; MICROSCALE THERMOPHORESIS; MOLECULAR DYNAMICS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; HEK293 CELL LINE; METABOLISM; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIGENS, CD44; CELL LINE, TUMOR; HEK293 CELLS; HEPATOCYTE GROWTH FACTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MET; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84938894409     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20150093     Document Type: Article

References (41)

1. Orian-Rousseau, V. and Ponta, H. (2008) Adhesion proteins meet receptors: a common theme? Adv. Cancer Res 101, 63-92 CrossRef PubMed
2. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P. and Ornitz, D.M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848 CrossRef PubMed
3. Steinfeld, R., Van Den Berghe, H. and David, G. (1996) Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J. Cell Biol. 133, 405-416 CrossRef PubMed
4. Filla, M.S., Dam, P. and Rapraeger, A.C. (1998) The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity. J. Cell Physiol. 174, 310-321 CrossRef PubMed
5. Clasper, S., Vekemans, S., Fiore, M., Plebanski, M., Wordsworth, P., David, G. and Jackson, D.G. (1999) Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J. Biol. Chem. 274, 24113-24123 CrossRef PubMed
6. Bonneh-Barkay, D., Shlissel, M., Berman, B., Shaoul, E., Admon, A., Vlodavsky, I., Carey, D.J., Asundi, V.K., Reich-Slotky, R. and Ron, D. (1997) Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J. Biol. Chem. 272, 12415-12421 CrossRef PubMed
7. Kleeff, J., Ishiwata, T., Kumbasar, A., Friess, H., Buchler, M.W., Lander, A.D. and Korc, M. (1998) The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J. Clin. Invest. 102, 1662-1673 CrossRef PubMed
8. Spivak-Kroizman, T., Lemmon, M.A., Dikic, I., Ladbury, J.E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J. and Lax, I. (1994) Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79, 1015-1024 CrossRef PubMed
9. Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103, 211-225 CrossRef PubMed
10. Orian-Rousseau, V. and Sleeman, J. (2014) CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signals. Adv. Cancer Res. 123, 231-254 CrossRef PubMed
11. Greenfield, B., Wang, W.C., Marquardt, H., Piepkorn, M., Wolff, E.A., Aruffo, A. and Bennett, K.L. (1999) Characterization of the heparan sulfate and chondroitin sulfate assembly sites in CD44. J. Biol. Chem. 274, 2511-2517 CrossRef PubMed
12. Orian-Rousseau, V. (2010) CD44, a therapeutic target for metastasising tumours. Eur. J. Cancer 46, 1271-1277 CrossRef PubMed
13. Hasenauer, S., Malinger, D., Koschut, D., Pace, G., Matzke, A., von Au, A. and Orian-Rousseau, V. (2013) Internalization of Met requires the co-receptor CD44v6 and its link to ERM proteins. PloS ONE 8, e62357 CrossRef PubMed
14. Matzke, A., Herrlich, P., Ponta, H. and Orian-Rousseau, V. (2005) A five-amino-acid peptide blocks Met- and Ron-dependent cell migration. Cancer Res 65, 6105-6110 CrossRef PubMed
15. Tremmel, M., Matzke, A., Albrecht, I., Laib, A.M., Olaku, V., Ballmer-Hofer, K., Christofori, G., Heroult, M., Augustin, H.G., Ponta, H. and Orian-Rousseau, V. (2009) A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis. Blood 114, 5236-5244 CrossRef PubMed
16. Staton, C.A., Kumar, I., Reed, M.W. and Brown, N.J. (2007) Neuropilins in physiological and pathological angiogenesis. J. Pathol. 212, 237-248 CrossRef PubMed
17. Ballmer-Hofer, K., Andersson, A.E., Ratcliffe, L.E. and Berger, P. (2011) Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output. Blood 118, 816-826 CrossRef PubMed
18. Orian-Rousseau, V., Chen, L., Sleeman, J.P., Herrlich, P. and Ponta, H. (2002) CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 16, 3074-3086 CrossRef PubMed
19. Cecchi, F., Rabe, D.C. and Bottaro, D.P. (2012) Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opin. Ther. Targets 16, 553-572 CrossRef PubMed
20. Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H. and Herrlich, P. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65, 13-24 CrossRef PubMed
21. Gherardi, E., Youles, M.E., Miguel, R.N., Blundell, T.L., Iamele, L., Gough, J., Bandyopadhyay, A., Hartmann, G. and Butler, P.J. (2003) Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. U.S.A. 100, 12039-12044 CrossRef PubMed
22. Niemann, H.H., Jager, V., Butler, P.J., van den Heuvel, J., Schmidt, S., Ferraris, D., Gherardi, E. and Heinz, D.W. (2007) Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InlB. Cell 130, 235-246 CrossRef PubMed
23. Dietz, M.S., Hasse, D., Ferraris, D.M., Gohler, A., Niemann, H.H. and Heilemann, M. (2013) Single-molecule photobleaching reveals increased MET receptor dimerization upon ligand binding in intact cells. BMC Biophys 6, 6 CrossRef PubMed
24. Shen, Y., Naujokas, M., Park, M. and Ireton, K. (2000) InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase. Cell 103, 501-510 CrossRef PubMed
25. Orian-Rousseau, V., Morrison, H., Matzke, A., Kastilan, T., Pace, G., Herrlich, P. and Ponta, H. (2007) Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin. Mol. Biol. Cell 18, 76-83 CrossRef PubMed
26. Birchmeier, C., Birchmeier, W., Gherardi, E. and Vande Woude, G.F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925 CrossRef PubMed
27. Mamluk, R., Gechtman, Z., Kutcher, M.E., Gasiunas, N., Gallagher, J. and Klagsbrun, M. (2002) Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain. J. Biol. Chem. 277, 24818-24825 CrossRef PubMed
28. Jakobsson, L., Kreuger, J., Holmborn, K., Lundin, L., Eriksson, I., Kjellen, L. and Claesson-Welsh, L. (2006) Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev. Cell 10, 625-634 CrossRef PubMed
29. Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C. and Shima, D.T. (2002) Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 16, 2684-2698 CrossRef PubMed
30. Lokker, N.A., Mark, M.R., Luis, E.A., Bennett, G.L., Robbins, K.A., Baker, J.B. and Godowski, P.J. (1992) Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J 11, 2503-2510 PubMed
31. Kirchhofer, D., Lipari, M.T., Santell, L., Billeci, K.L., Maun, H.R., Sandoval, W.N., Moran, P., Ridgway, J., Eigenbrot, C. and Lazarus, R.A. (2007) Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist. Proc. Natl. Acad Sci. U.S.A. 104, 5306-5311 CrossRef PubMed
32. Stamos, J., Lazarus, R.A., Yao, X., Kirchhofer, D. and Wiesmann, C. (2004) Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. EMBO J 23, 2325-2335 CrossRef PubMed
33. Presta, M., Maier, J.A., Rusnati, M. and Ragnotti, G. (1989) Basic fibroblast growth factor: production, mitogenic response, and post-receptor signal transduction in cultured normal and transformed fetal bovine aortic endothelial cells. J. Cell Physiol. 141, 517-526 CrossRef PubMed
34. Rapraeger, A.C., Krufka, A. and Olwin, B.B. (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705-1708 CrossRef PubMed
35. Mazzone, M., Basilico, C., Cavassa, S., Pennacchietti, S., Risio, M., Naldini, L., Comoglio, P.M. and Michieli, P. (2004) An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice. J. Clin. Invest. 114, 1418-1432 CrossRef PubMed
36. Luo, B.H. and Springer, T.A. (2006) Integrin structures and conformational signaling. Curr. Opin. Cell Biol. 18, 579-586 CrossRef PubMed
37. Xiong, J.P., Mahalingham, B., Alonso, J.L., Borrelli, L.A., Rui, X., Anand, S., Hyman, B.T., Rysiok, T., Muller-Pompalla, D., Goodman, S.L. and Arnaout, M.A. (2009) Crystal structure of the complete integrin alphaVbeta3 ectodomain plus an alpha/beta transmembrane fragment. J. Cell Biol. 186, 589-600 CrossRef PubMed
38. Lemmon, M.A., Schlessinger, J. and Ferguson, K.M. (2014) The EGFR family: not so prototypical receptor tyrosine kinases. Cold Spring Harb. Perspect. Biol. 6, a020768 CrossRef PubMed
39. Niemann, H.H. (2011) Structural insights into Met receptor activation. Eur. J. Cell Biol. 90, 972-981 CrossRef PubMed
40. Gherardi, E., Sandin, S., Petoukhov, M.V., Finch, J., Youles, M.E., Ofverstedt, L.G., Miguel, R.N., Blundell, T.L., Vande Woude, G.F., Skoglund, U. and Svergun, D.I. (2006) Structural basis of hepatocyte growth factor/scatter factor and MET signalling. Proc. Natl. Acad Sci. U.S.A. 103, 4046-4051 CrossRef PubMed
41. Li, E. and Hristova, K. (2010) Receptor tyrosine kinase transmembrane domains: function, dimer structure and dimerization energetics. Cell Adh. Migr. 4, 249-254 CrossRef PubMed